Nainika Nanda

Nainika Nanda practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Nainika Nanda's NPI, 1700382470, was assigned on April 2, 2018. Nainika Nanda graduated from West Virginia University School of Medicine in 2018. Nainika Nanda holds Pennsylvania license MD486361.

Nainika Nanda's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Nainika Nanda's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Nainika Nanda is also affiliated with Hospital of the University of Pennsylvania. The medical group on file is Premier ENT Associates. Dmand AI also links Nainika Nanda to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Nainika Nanda practices, 5 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Nainika Nanda's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dmand AI has Nainika Nanda's licenses on file in 4 states: Pennsylvania, California, New Jersey and Wisconsin.

CMS data shows 28 Medicare services from Nainika Nanda across 2 procedure codes in 2024, for 46 Medicare patients. Medicare paid $2,235 for them.

CMS counts 46 Medicare patients who saw Nainika Nanda in 2024. The largest group is 65 to 74, with 20 patients. 75% of them have high cholesterol, and 65% have high blood pressure. 30% are also on Medicaid. Their average risk score is 2.06, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Nainika Nanda's median patient age at 60, with 53% women.

In 2024, Nainika Nanda wrote 333 Medicare Part D claims for 115 patients. 93% of them were for generic drugs. CMS names the drug for 214 of them, across 6 drugs with 11 or more claims each, at $10,961 in total drug cost. In 2022, CMS named 31 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Nainika Nanda for performance year 2024, reported as part of a group. Nainika Nanda accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 12 papers to Nainika Nanda, published from 2014 to 2025. 2018 was the busiest year, with 2. The most frequent topics are Laryngostenosis, Constriction, Pathologic and Disease Progression. Nainika Nanda has published most often in Laryngoscope. Nainika Nanda's most frequent co-authors are Habib George Zalzal, Seth H. Dailey, MD and David O. Francis, MD, MS.

CMS Open Payments shows 14 general payments to Nainika Nanda from 7 drug and device companies from 2020 to 2025. Education make up the largest share, 57% of the total. Stryker Corporation paid the most, $620.

Nainika Nanda graduated from West Virginia University School of Medicine in 2018.